GB0618199D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB0618199D0
GB0618199D0 GBGB0618199.4A GB0618199A GB0618199D0 GB 0618199 D0 GB0618199 D0 GB 0618199D0 GB 0618199 A GB0618199 A GB 0618199A GB 0618199 D0 GB0618199 D0 GB 0618199D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0618199.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB0618199.4A priority Critical patent/GB0618199D0/en
Publication of GB0618199D0 publication Critical patent/GB0618199D0/en
Priority to PCT/GB2007/003499 priority patent/WO2008032093A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0618199.4A 2006-09-15 2006-09-15 Cancer treatment Ceased GB0618199D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0618199.4A GB0618199D0 (en) 2006-09-15 2006-09-15 Cancer treatment
PCT/GB2007/003499 WO2008032093A1 (en) 2006-09-15 2007-09-14 Cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0618199.4A GB0618199D0 (en) 2006-09-15 2006-09-15 Cancer treatment

Publications (1)

Publication Number Publication Date
GB0618199D0 true GB0618199D0 (en) 2006-10-25

Family

ID=37310003

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0618199.4A Ceased GB0618199D0 (en) 2006-09-15 2006-09-15 Cancer treatment

Country Status (2)

Country Link
GB (1) GB0618199D0 (en)
WO (1) WO2008032093A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424497D0 (en) * 2004-11-05 2004-12-08 Univ Sheffield Anti-inflammatory agent
GB0424494D0 (en) * 2004-11-05 2004-12-08 Univ Sheffield Use

Also Published As

Publication number Publication date
WO2008032093A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
ZA200807934B (en) Cancer treatments
IL197315A0 (en) Treatment of cancer
GB0624874D0 (en) Treatment
GB0600692D0 (en) Well treatment
EP2023950A4 (en) Urodilatin cancer treatment
GB0711342D0 (en) Well treatment
IL238394A0 (en) Cancer treatment method
EP2088862A4 (en) Cancer treatment method
GB0607952D0 (en) Novel treatment
GB0716784D0 (en) Well treatment
HK1225304A1 (en) Treating bone cancer
GB0707556D0 (en) Treatment for cancer
GB0604460D0 (en) Treatment
GB0809046D0 (en) Cancer treatment
EP2056839A4 (en) Combination approaches to cancer treatment
GB0710871D0 (en) Cancer treatment
GB0525535D0 (en) Tumour treatment
GB0507685D0 (en) Cancer treatment
GB0600903D0 (en) Treatment of cancer
GB0604741D0 (en) Cancer Treatment
GB0618199D0 (en) Cancer treatment
GB0619271D0 (en) Treating cancer
GB0723503D0 (en) Cancer treatment
GB0700493D0 (en) Cancer treatment
GB0606702D0 (en) Cancer therapeutic

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)